• About
  • News
  • Office Locator
  • Careers
  • Contact Us
  • Subscribe
CohnReznick
  • Industries
  • Services
  • Insights
  • Events
  • People
  • About
  • News
  • Office Locator
  • Careers
  • Contact Us
CohnReznick
  • Industries
    • Recent Insights

      • IRS: Amounts used as ‘payroll costs’ in 2020 PPP loan forgiveness applications are ineligible for retroactive 2020 Employee Retention Credits

      • How industry best practices can help cannabis companies strengthen costing and systems to improve profit margins

      • View More
    • Consumer & Industrial

      • Hospitality
      • Manufacturing & Distribution
      • Consumer

      Financial Sponsors & Financial Services

      • Broker Dealers
      • Independent Sponsors
      • Family Offices
      • Hedge Funds
      • Private Equity
      • Small Business Investment Companies (SBICs)
      • Special Purpose Acquisition Companies (SPACs) Services
      • Venture Capital
    • Life Sciences & Healthcare

      • Life Sciences
      • Healthcare

      Public Sector

      • Government Contracting
      • Government
      • Not-for-Profit & Education

      Real Estate

      • Affordable Housing
      • Commercial Real Estate
      • Construction
      • Corporate Real Estate
      • Corporate Real Estate
      • Opportunity Zones
      • Tax Credits
    • Renewable Energy

      Technology & Media

      Private Clients

      • Entertainment
      • Law Firms
      • Medical Practices
      • Private Clients

      Cannabis

  • Services
    • Recent Insights

      • For independent sponsors, access to capital is no longer a constraint

      • Introducing Hospitality Quarterly: Strategic insights for transforming your business (2021 Q1: Business Agility)

      • View More
    • Advisory

      • Accounting Advisory
      • Analytics & Data
      • CFO Advisory
      • CIO Advisory
      • Cybersecurity, Technology Risk, Privacy
      • Emergency Management
      • Emergency Rental Assistance Program
      • Enterprise Technology Solutions
      • Project Finance and Consulting
      • Real Estate Advisory
      • Restructuring & Dispute Resolution
      • Risk Advisory
      • Transactions
      • Valuation
    • Accounting & Assurance

      • Accounting Advisory
      • Accounting Services
      • Attest & Audit
      • Employee Benefit Plans
      • Lease Accounting
      • Paycheck Protection Program (PPP) Loan Forgiveness Assistance

      Tax

      • Federal Tax
      • International Tax
      • Exempt Organizations Tax Services
      • Private Clients
      • SBA Disaster Loan Assistance
      • State & Local Tax
      • Tax Credits
      • Trusts & Estates
    • Affiliated Companies

      • Asset Management & Insurance
      • Benefits Brokerage & Consulting
      • Capital Markets Advisory
      • Corporate Real Estate
      • Equity & Capital Placement
      • Government Contracting Technology Consulting
      • Risk Insurance Consulting
  • Insights
    • Recent Insights

      • How hospitals and health systems can use price transparency to become more patient centric

      • View More
    • Topics

      • CFOs: From survival to revival
      • CohnReznick & Major League Baseball®
      • Coronavirus Resource Center
      • Creating value by building trust
      • GovCon360° Resource Center
      • All Insights
      • Integrated business planning
      • Optimizing outcomes for distressed situations
      • Housing tax credit data analysis and report
      • SPACs: An alternative to traditional IPOs
      • Strategic tax issues for capital markets
  • Events
  • People
  1. CohnReznick: Advisory, Assurance, Tax Firm
  2. Industries
  3. Life Sciences & Healthcare
  4. Life Sciences
    Share CohnReznick
    Share
  • Print

Life Sciences

For a life sciences company, ongoing innovation, access to capital, and the ability to obtain regulatory approval are the cornerstones for success. Improving  operational, financial, and risk management practices as you grow enhances your ability to attract investors, commercialize, and exit when the time is right. CohnReznick’s Life Sciences Industry specialists serve as trusted accounting, tax, and business advisors to assist you in making critical go-forward decisions. 

First-hand experience navigating funding, governance, and other growth-related issues within the life sciences industry prepares us to advise early-stage through mature organizations.

WIDE SECTOR EXPERTISE

Biotechnology, pharmaceutical services, medical devices, diagnostics, and therapeutics companies are among our client roster and speak to our experience in this industry.

SPECIALIZED KNOWLEDGE

We work with complex licensing deals, tax-sensitive financing structures, purchase price allocations and stock valuations, and provide specialized advisory services.

PROACTIVE INDUSTRY PARTICIPATION

Our professionals are actively involved with industry professional associations, trade organizations, and investor groups.

PCAOB REGISTRATION

CohnReznick is registered with the Public Company Accounting Oversight Board (PCAOB), providing audit services and advising CEOs, CFOs, and audit committees on SEC rulings and compliance with changing accounting requirements.
CohnReznick’s accounting, tax, and advisory services help private, public and venture and private equity-backed life sciences companies manage financial growth across their life cycle. We also provide services specific to the life sciences industry:

CAPITAL MARKETS ACCESS

Our experience with the capital markets community supports both buy and sell-side M&A transactions. We can take your company through a private equity, venture capital, corporate, or IPO transaction as your auditor or by providing consulting services such as valuation, financial structuring, and the corporate governance advisory you need as you grow.

TAX PLANNING AND CREDITS

Our in-depth knowledge of the applicable tax code, and experience with orphan drug and research and development tax credits, allows us to help you maximize tax advantages. This extends to transfer pricing and international tax structuring if your business has overseas operations.

LICENSING AGREEMENTS

We help structure agreements and put systems in place to ensure compliance over the duration of contracts for these essential sources of income and market exposure.

CYBERSECURITY

We identify threats and protect life sciences companies from intrusions, threat, and sabotage. Our services help you maintain the confidentiality and integrity of technology resources and data.

Related Services

  • Lease Accounting
  • Attest & Audit
  • Risk Advisory
  • Tax Credits
  • Transactions
  • Valuation
Ravi Raghunathan
CPA, Partner - Life Sciences Industry Leader
View full biography
Contact Ravi
On-Demand Webinar: Government Funding for Life Sciences Companies – How to Obtain Awards and Master Compliance
Watch now
Role of Technology, Data, & Analytics For Commercial & Innovative Life Sciences Companies Adjusting to Coronavirus
Learn more
2020 Life Sciences M&A Outlook: Oncology, CROs Among Sectors Showing Promise
Learn more
39
Idea

With companies staying private longer these days, don’t be in a big hurry for your IPO. Capital raising activities and burn rate should reflect current market conditions.

Let's get going. 99 more ideas for creating value, accelerating growth, and managing risk

Learn more about Emerging Markets

Explore our services

To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video

Industry Insight: Changing Needs for Growth-Focused Companies
Play video
Related Insights
  • Insight
    Life Sciences IPO Market Remains Consistently Strong in 2018, With Q3 No Exception
    Life sciences with biotech companies paving the way represent a significant portion of IPOs in 2018.
  • Insight
    The Role of the Controller in a Life Sciences Company Has Transformed – Will You Be Left Behind?
    The life sciences sector is growing rapidly and this presents increased demands and new challenges for today’s controller.
  • Insight
    2018 May Be Banner Year for Life Sciences Deals
    On the heels of the January 8-11, 2018 JP Morgan Annual Healthcare Conference, there is strong momentum among the life sciences industry for 2018. Despite the existing challenges of raising capital in the public markets, this year may be ideal and advantageous for life science companies to get financial deals done. But they need to act quickly.
  • Contact Us
  • Subscribe
  • Follow:
Industries
Consumer & Industrial
  • Hospitality
  • Manufacturing & Distribution
  • Consumer
Financial Sponsors & Financial Services
  • Broker Dealers
  • Independent Sponsors
  • Family Offices
  • Hedge Funds
  • Private Equity
  • Small Business Investment Companies (SBICs)
  • Special Purpose Acquisition Companies (SPACs) Services
  • Venture Capital
Life Sciences & Healthcare
  • Life Sciences
  • Healthcare
Public Sector
  • Government Contracting
  • Government
  • Not-for-Profit & Education
Real Estate
  • Affordable Housing
  • Commercial Real Estate
  • Construction
  • Corporate Real Estate
  • Corporate Real Estate
  • Opportunity Zones
  • Tax Credits
Renewable Energy
Technology & Media
Private Clients
  • Entertainment
  • Law Firms
  • Medical Practices
  • Private Clients
Cannabis
Services
Advisory
  • Accounting Advisory
  • Analytics & Data
  • CFO Advisory
  • CIO Advisory
  • Cybersecurity, Technology Risk, Privacy
  • Emergency Management
  • Emergency Rental Assistance Program
  • Enterprise Technology Solutions
  • Project Finance and Consulting
  • Real Estate Advisory
  • Restructuring & Dispute Resolution
  • Risk Advisory
  • Transactions
  • Valuation
Accounting & Assurance
  • Accounting Advisory
  • Accounting Services
  • Attest & Audit
  • Employee Benefit Plans
  • Lease Accounting
  • Paycheck Protection Program (PPP) Loan Forgiveness Assistance
Tax
  • Federal Tax
  • International Tax
  • Exempt Organizations Tax Services
  • Private Clients
  • SBA Disaster Loan Assistance
  • State & Local Tax
  • Tax Credits
  • Trusts & Estates
Affiliated Companies
  • Asset Management & Insurance
  • Benefits Brokerage & Consulting
  • Capital Markets Advisory
  • Corporate Real Estate
  • Equity & Capital Placement
  • Government Contracting Technology Consulting
  • Risk Insurance Consulting
Insights
CFOs: From survival to revival
CohnReznick & Major League Baseball®
  • Business of Food
  • Community Development
  • Community Outreach
  • Elevating The Fan (Customer) Experience
  • Managing for Success
  • Mayor of the City
Coronavirus Resource Center
  • Federal coronavirus resources: Legislation, loans, and tax relief
  • SALT coronavirus resources
Creating value by building trust
GovCon360° Resource Center
  • The Cybersecurity Maturity Model Certification (CMMC)
Integrated business planning
  • Integrated business planning for manufacturing
  • Integrated business planning for retail
Optimizing outcomes for distressed situations
Housing tax credit data analysis and report
SPACs: An alternative to traditional IPOs
Strategic tax issues for capital markets
Events
People
Contact Us
Offices
© 2020 CohnReznick LLP, All Rights Reserved. Terms of Use & Disclosures Privacy Policy

“CohnReznick” refers to CohnReznick LLP or any of its subsidiaries or affiliates. Each entity is a separate legal entity and solely responsible for its own acts and/or omissions.

CohnReznick LLP is a member firm of the “Nexia International” network. Nexia International Limited does not deliver services in its own name or otherwise. Nexia International Limited and each of its member firms are separate legal entities and not part of a worldwide partnership.  Nexia International Limited does not accept any responsibility for the commission of any act, or omission to act by, or the liabilities of, any of its members.